Considerations for rare variants in drug metabolism genes and the clinical implications.

Abstract excerpt

INTRODUCTION: Large-scale whole genome and exome resequencing studies have revealed that humans have a high level of deleterious rare variation, which has important implications for the design of future pharmacogenetics studies. AREAS COVERED: Current pharmacogenetic guidelines focus on the implementation of common variation into dosing guidelines. However, it is becoming apparent that rare variation may also...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biotransformation
• Share to Cytochrome P-450 Enzyme System